The pill formulation of zanubrutinib (Brukinsa; BeOne) is currently accepted for all 5 indications across many hematological cancers. The modified stem cells source the body with myeloid (immune) cells that make the ARSA enzyme, which assists break down the hazardous build-up of sulfatides and will halt the development of MLD. https://libmeldy50482.blogscribble.com/36001981/a-secret-weapon-for-lenmeldy